FGFR1 was reported to be highly expressed in colorectal adenoma and cancer, and activating mutations and overexpression of FGFR1 have been shown to trigger the development of various cancers, e.g., breast, bladder, ovarian cancer, renal cell, and squamous cell lung cancers [33–35]. This evidence concerns the gene FGFR1 and ovarian cancer.